Valneva SE VALN
NASDAQ VALN
$6.89 -0.17 (-2.41%)
At close: Sep 4, 2026 · 4:00 PM EDT

Valneva SE (VALN) Goodwill & Intangibles (2019 - 2026)

Valneva SE (VALN) posted Goodwill & Intangibles of $25.3 million for Q1 2026, down 2.66% sequentially from $26.0 million in Q4 2025, and down 2.12% YoY from $25.9 million in Q1 2025.

Analysis

Valneva SE (VALN) Goodwill & Intangibles (2019 - 2026) Analysis & Trends

Valneva SE has reported Goodwill & Intangibles for 8 years, with the latest figure at $25.3 million in Q1 2026.

  • Quarterly Goodwill & Intangibles fell 2.12% year-over-year to $25.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $25.3 million (down 2.12% YoY) and the FY2025 annual result came in at $26.0 million, down 4.84% from the prior year.
  • Goodwill & Intangibles fell to $25.3 million in Q1 2026 per VALN's latest filing, from $26.0 million in the prior quarter.
  • Over five years, Goodwill & Intangibles peaked at $36.8 million in Q3 2024 and troughed at $25.3 million in Q1 2026.
  • A 5-year average of $28.9 million and a median of $27.5 million in 2023 frame the typical range for Goodwill & Intangibles.
  • The sharpest annual moves came in 2024 and 2025: Goodwill & Intangibles gained 28.22% in 2024, then decreased 26.63% in 2025.
  • Over 5 years, Goodwill & Intangibles stood at $29.3 million in 2022, then declined by 6.09% to $27.5 million in 2023, then retreated by 1.88% to $27.0 million in 2024, then declined by 3.61% to $26.0 million in 2025, then dropped by 2.66% to $25.3 million in 2026.
  • According to Business Quant data, Goodwill & Intangibles over the past three periods registered $25.3 million, $26.0 million, and $27.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Valneva SE 578.54 Mn 437.28 Mn 1.86 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 24.31 Mn
Mar 31, 2026 25.32 Mn
Dec 31, 2025 26.02 Mn
Sep 30, 2025 26.97 Mn
Jun 30, 2025 26.97 Mn
Mar 31, 2025 25.87 Mn
Dec 31, 2024 26.99 Mn
Sep 30, 2024 36.77 Mn
Jun 30, 2024 26.05 Mn
Mar 31, 2024 27.00 Mn
Dec 31, 2023 27.51 Mn
Sep 30, 2023 28.67 Mn
Jun 30, 2023 29.54 Mn
Mar 31, 2023 29.94 Mn
Dec 31, 2022 29.29 Mn
Sep 30, 2022 29.90 Mn
Jun 30, 2022 32.77 Mn
Mar 31, 2022 35.65 Mn
Dec 31, 2021 37.41 Mn
Dec 31, 2020 42.22 Mn